FDA Inspection 1314570 — Baylor, Scott, and White, ART Program
The FDA completed an inspection of Baylor, Scott, and White, ART Program on April 14, 2026 in Temple, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 14, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Temple, TX (United States)